We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products. Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.

Products

Not all products and/or indications are available in all territories

When Choosing Antivenin, Look at Cost Per Treatment—Not Cost Per Vial

BTG Pharmaceuticals 02 May 2023

Recent NASBR data suggests that the difference in total treatment cost between antivenom products is probably much less than healthcare providers think.

Learn more

Why We Are Joining the UN Global Compact as Part of Our Broader Strategy

SERB Pharmaceuticals 04 August 2022

Learn how BTG Pharmaceuticals, a SERB company, is becoming better environmental stewards, more responsive to our people and respectful of our responsibilities as an organisation
 

Learn more

Household Fires Can Cause Cyanide Poisoning – Here’s What Medical Professionals Can Do

Jami Johnson, PharmD, Medical Science Liaison 31 March 2022

Smoke inhalation from domestic fires is the most common cause of cyanide poisoning in developed countries, with significant levels of cyanide present in up to 35% of all fire victims.
 

Learn more